IOL CHEMICALS & PHARM. | THEMIS MEDICARE | IOL CHEMICALS & PHARM./ THEMIS MEDICARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.2 | 69.4 | 19.0% | View Chart |
P/BV | x | 1.5 | 5.7 | 26.5% | View Chart |
Dividend Yield | % | 1.0 | 0.2 | 434.0% |
IOL CHEMICALS & PHARM. THEMIS MEDICARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
THEMIS MEDICARE Mar-23 |
IOL CHEMICALS & PHARM./ THEMIS MEDICARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 1,434 | 37.4% | |
Low | Rs | 272 | 692 | 39.3% | |
Sales per share (Unadj.) | Rs | 377.6 | 385.1 | 98.1% | |
Earnings per share (Unadj.) | Rs | 23.7 | 61.8 | 38.3% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 73.3 | 43.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0.50 | 800.0% | |
Avg Dividend yield | % | 1.0 | 0 | 2,102.9% | |
Book value per share (Unadj.) | Rs | 256.8 | 368.9 | 69.6% | |
Shares outstanding (eoy) | m | 58.71 | 9.20 | 638.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 2.8 | 38.8% | |
Avg P/E ratio | x | 17.1 | 17.2 | 99.2% | |
P/CF ratio (eoy) | x | 12.8 | 14.5 | 88.3% | |
Price / Book Value ratio | x | 1.6 | 2.9 | 54.6% | |
Dividend payout | % | 16.9 | 0.8 | 2,087.0% | |
Avg Mkt Cap | Rs m | 23,743 | 9,784 | 242.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 661 | 254.3% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 3,543 | 625.7% | |
Other income | Rs m | 256 | 115 | 222.6% | |
Total revenues | Rs m | 22,427 | 3,658 | 613.1% | |
Gross profit | Rs m | 2,257 | 811 | 278.4% | |
Depreciation | Rs m | 462 | 105 | 439.8% | |
Interest | Rs m | 165 | 96 | 172.2% | |
Profit before tax | Rs m | 1,887 | 725 | 260.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 156 | 317.1% | |
Profit after tax | Rs m | 1,391 | 569 | 244.5% | |
Gross profit margin | % | 10.2 | 22.9 | 44.5% | |
Effective tax rate | % | 26.2 | 21.5 | 121.9% | |
Net profit margin | % | 6.3 | 16.1 | 39.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 2,748 | 351.8% | |
Current liabilities | Rs m | 5,025 | 1,494 | 336.4% | |
Net working cap to sales | % | 20.9 | 35.4 | 59.1% | |
Current ratio | x | 1.9 | 1.8 | 104.6% | |
Inventory Days | Days | 43 | 87 | 49.6% | |
Debtors Days | Days | 8 | 1,494 | 0.6% | |
Net fixed assets | Rs m | 11,017 | 2,494 | 441.7% | |
Share capital | Rs m | 587 | 92 | 637.9% | |
"Free" reserves | Rs m | 14,490 | 3,302 | 438.9% | |
Net worth | Rs m | 15,077 | 3,394 | 444.3% | |
Long term debt | Rs m | 0 | 284 | 0.0% | |
Total assets | Rs m | 20,684 | 5,242 | 394.6% | |
Interest coverage | x | 12.5 | 8.6 | 145.1% | |
Debt to equity ratio | x | 0 | 0.1 | 0.0% | |
Sales to assets ratio | x | 1.1 | 0.7 | 158.6% | |
Return on assets | % | 7.5 | 12.7 | 59.3% | |
Return on equity | % | 9.2 | 16.8 | 55.0% | |
Return on capital | % | 13.6 | 22.3 | 61.0% | |
Exports to sales | % | 26.7 | 39.4 | 67.9% | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | 1,395 | 425.1% | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 1,395 | 425.1% | |
Fx outflow | Rs m | 6,052 | 477 | 1,267.8% | |
Net fx | Rs m | -122 | 918 | -13.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 161 | 759.8% | |
From Investments | Rs m | -1,200 | -240 | 500.8% | |
From Financial Activity | Rs m | -41 | 1 | -3,022.1% | |
Net Cashflow | Rs m | -18 | -77 | 23.8% |
Indian Promoters | % | 48.2 | 57.6 | 83.7% | |
Foreign collaborators | % | 0.0 | 9.6 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.0 | 8,500.0% | |
FIIs | % | 1.4 | 0.0 | 14,000.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 32.8 | 157.8% | |
Shareholders | 130,003 | 11,244 | 1,156.2% | ||
Pledged promoter(s) holding | % | 0.0 | 2.8 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | THEMIS MEDICARE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.18% | -1.25% | -0.44% |
1-Month | -4.51% | -3.38% | 2.15% |
1-Year | -4.09% | -84.95% | 49.82% |
3-Year CAGR | -12.01% | -12.39% | 14.21% |
5-Year CAGR | 15.35% | -6.37% | 19.19% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the THEMIS MEDICARE share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of THEMIS MEDICARE the stake stands at 67.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of THEMIS MEDICARE.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
THEMIS MEDICARE paid Rs 0.5, and its dividend payout ratio stood at 0.8%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of THEMIS MEDICARE.
For a sector overview, read our pharmaceuticals sector report.
After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.